Postenucleation orbits in retinoblastoma: Treatment with 125I brachytherapy

International Journal of Radiation Oncology Biology Physics

Volumn 54, Issue 5, 2002, Pages 1446-1454

  Stannard, Clare ^a   Sealy, Ross ^a   Hering, Egbert ^a   Hough, Jan ^a   Knowles, Ruth ^a   Lecuona, Karin ^a   Reddi, V Bala ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Frere Hospital   (South Africa)

Author keywords

125I; Brachytherapy; Eye tumors; Postenucleation orbits; Retinoblastoma

Indexed keywords

CHEMOTHERAPY; DISEASES; IRRADIATION; OPHTHALMOLOGY; TUMORS;

BRACHYTHERAPHY;

RADIOTHERAPY;

IODINE 125; NYLON;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CARCINOGENESIS; CHOROID; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; ENUCLEATION; ESTHETICS; EYELID; FOLLOW UP; HUMAN; IMPLANT; IRRADIATION; OPTIC NERVE; ORBIT DISEASE; PRIORITY JOURNAL; PROPHYLAXIS; RADIATION DOSE; RECURRENT DISEASE; RETINOBLASTOMA; RISK FACTOR; SCLERA; SOUTH AFRICA; SURFACE PROPERTY;

ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; EYE NEOPLASMS; FOLLOW-UP STUDIES; HEAT; HUMANS; INFANT; IODINE RADIOISOTOPES; NEOPLASM METASTASIS; RADIOMETRY; RETINOBLASTOMA; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036891088     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)03756-2     Document Type: Conference Paper

References (50)

1. Sanders B.M., Draper G.J., Kingston J.E. Retinoblastoma in Great Britain 1969-1980 Incidence, treatment and survival . Br J Ophthalmol. 72:1988;576-583.
2. Abramson D.H., Niksarli K., Ellsworth R.M., et al. Changing trends in the management of retinoblastoma 1951-1996 vs 1966-1980. J Paediatr Ophthalmol Strabismus. 31:1994;32-37.
3. Shields C.A., Shields J.A. Recent developments in the management of retinoblastoma. J Paediatr Ophthalmol Strabismus. 36:1999;8-18.
4. Gaitan-Yanguas M. Retinoblastoma Analysis of 235 cases . Int J Radiat Oncol Biol Phys. 4:1978;359-365.
5. Erwenne C., Franco E. Age and lateness of referral as determinants of extraocular retinoblastoma. Ophthalmol Paediatr Genet. 10:1989;179-184.
6. Menon B.S., Reddy S.C., Wan Maziah W.M., et al. Extraocular retinoblastoma. Med Paediatr Oncol. 35:2000;75-76.
7. Carbajal U.M. Observations on retinoblastoma. Am J Ophthalmol. 45:1958;391-402.
8. Zimmerman L.E. The registry of ophthalmic pathology Past, present and future . Trans Am Acad Ophthalmol Otolaryngol. 65:1961;88-93.
9. Brown D.H. The clinicopathology of retinoblastoma. Am J Ophthalmol. 61:1966;508-514.
10. Stannard C., Lipper S., Sealy R., et al. Retinoblastoma Correlation of invasion of the optic nerve and choroid with prognosis and metastases . Br J Ophthalmol. 63:1979;560-570.
11. Magramm I., Abramson D.H., Ellsworth R.M. Optic nerve involvement in retinoblastoma. Ophthalmology. 96:1989;217-222.
12. Rubin C.M., Robinson L.L., Cameron J.D., et al. Intraocular retinoblastoma group V An analysis of prognostic factors . J Clin Oncol. 3:1985;680-685.
13. Kopelman J.E., McLean I.W., Rosenberg S.H. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology. 94:1987;371-377.
14. Goble R.R., McKenzie J., Kingston J.E., et al. Orbital recurrence of retinoblastoma successfully treated by combined therapy. Br J Ophthalmol. 74:1990;97-98.
15. Khelfaoui F., Validire P., Auperin A., et al. Histopathologic risk factors in retinoblastoma A retrospective study of 172 patients treated in a single institution . Cancer. 77:1996;1206-1213.
16. Messmer E.P., Heinrich T., Hopping W., et al. Risk factors for metastases in patients with retinoblastoma. Ophthalmology. 98:1991;136-141.
17. Shields C.L., Shields J.A., Baez K.A., et al. Choroidal invasion of retinoblastoma Metastatic potential and clinical risk factors . Br J Ophthalmol. 77:1993;544-548.
18. Reese A.B. Tumors of the eye. 1951;138 Cassell and Company, London.
19. MacKay C.J., Abramson D.H., Ellsworth R.M. Metastatic patterns of retinoblastoma. Arch Ophthalmol. 102:1984;391-396.
20. Hungerford J., Kingston J., Plowman N. Orbital recurrence of retinoblastoma. Ophthalmic Paediatr Genet. 8:1987;63-68.
21. Zelter M., Damel A., Gondalez G., et al. A prospective study on the treatment of retinoblastoma in 72 patients. Cancer. 68:1991;1685-1690.
22. Doz F., Khelfaoui F., Mosseri V., et al. The role of chemotherapy in orbital involvement of retinoblastoma The experience of a single institution . Cancer. 74:1994;723-732.
23. Petersen R.A., Friend S.H., Albert D.M. Prolonged survival in a child with metastatic retinoblastoma. J Paediatr Ophthalmol Strabismus. 24:1987;247-248.
24. Schwartzman E., Chantada G., Fandino A., et al. Results of a stage-based protocol for the treatment of retinoblastoma. J Clin Oncol. 14:1996;1532-1536.
25. Kiralti H., Bilgic S., Ozerdem U. Management of massive orbital involvement of intraocular retinoblastoma. Ophthalmology. 105:1998;322-326.
26. Pradhan D.G., Sandridge A.L., Mullaney P., et al. Radiation therapy for retinoblastoma - A retrospective review of 120 patients. Int J Radiat Oncol Biol Phys. 39:1997;3-13.
27. Freeman C.R., Esseltine D.-L., Whitehead V.M., et al. Retinoblastoma The case for radiotherapy and for adjuvant chemotherapy . Cancer. 46:1980;1913-1918.
28. Howarth C., Meyer D., Hustu O. Stage-related combined modality treatment of retinoblastoma Results of a prospective study . Cancer. 45:1980;851-858.
29. Wolter J.R. Growth retardation of the orbital region after radiation treatment of retinoblastoma Causing a very typical physiognomy . J Paediatr Ophthalmol Strabismus. 11:1974;125-128.
30. Imhoff S.M., Mouritz M.P., Hofman P. Quantification of orbital and midfacial growth retardation after megavoltage irradiation in children with retinoblastoma. Ophthalmology. 103:1996;263-268.
31. Yue N.C., Benson M.L. The hour glass facial deformity as a consequence of orbital irradiation for bilateral retinoblastoma. Paediatr Radiol. 26:1996;421-423.
32. Kaste S.C., Chen G., Fontanesi J., et al. Orbital development in long term survivors of retinoblastoma. J Clin Oncol. 15:1997;1183-1189.
33. Doline S., Needleman H.L., Petersen R.A., et al. The effect of radiotherapy in the treatment of retinoblastoma upon the developing dentition. J Pediatr Ophthalmol Strabismus. 17:1980;109-113.
34. Pomarede R., Czernichow P., Zucker J.M., et al. Incidence of anterior pituitary deficiency after radiotherapy at an early age Study in retinoblastoma . Acta Paediatr Scand. 73:1984;115-119.
35. Abramson D.H., Frank C.M. Second non-ocular malignancies in survivors of bilateral retinoblastoma A possible age effect on radiation related risk . Ophthalmology. 105:1998;573-580.
36. Moll A.C., Kuik D.J., Bouter L.M., et al. Incidence and survival of retinoblastoma in the Netherlands A register based study 1862-1995 . Br J Ophthalmol. 81:1997;559-562.
37. Dawkins M.M., Wilson L.M.K., Burton H.S., et al. Radiotherapy, alkylating agents and risk of bone cancer after childhood cancer. J Natl Cancer Inst. 88:1996;270-277.
38. Sealy R., Le Roux P.L.M., Rapley F., et al. The treatment of ophthalmic tumours with low energy sources. Br J Radiol. 49:1976;551-554.
39. Sealy R. Some aspects of radiotherapy of tumours of the eye. Trans Coll Med South Afr. 21:1977;3-23.
40. Sealy R., Buret E., Cleminshaw H., et al. Progress in the use of iodine therapy for tumours of the eye. Br J Radiol. 53:1980;1052-1060.
41. Stannard C., Sealy R., Shackleton D., et al. The use of iodine-125 plaques in the treatment of retinoblastoma. Ophthalmic Paediatr Genet. 8:1987;89-93.
42. Hill J.C., Sealy R., Shackleton D., et al. Improved iodine-125 plaque design in the treatment of choroidal malignant melanoma. Am J Ophthalmol. 112:1991;682-688.
43. Stannard C.E., Sealy G.R.H., Hering E.R., et al. Malignant melanoma of the eyelid and palpebral conjunctiva treated with iodine-125 brachytherapy. Ophthalmology. 107:2000;951-958.
44. Stannard C., Sealy R., Hering E., et al. Localised whole eye radiotherapy for retinoblastoma using an iodine-125 applicator, "claws" Int J Radiat Oncol Biol Phys. 51:2001;399-409.
45. Sealy R., Stannard C., Shackelton D. Improved cosmesis in retinoblastoma patients treated with iodine-125 orbital irradiation. Ophthalmic Paediatr Genet. 8:1987;95-99.
46. 192Ir gamma rays on the roots of Vicia faba using a specially designed applicator. Br J Radiol. 53:1980;255-258.
47. Scalliet P., Wambersie A. Which RBE for iodine-125 in clinical applications. Radiother Oncol. 9:1987;221-230.
48. Draper G.J., Sanders B.M., Kingston J.E. Retinoblastoma and second primary neoplasms. Br J Cancer. 53:1986;661-671.
49. Gombos D.S., Kingston J.E., Hungerford J.L. Secondary leukaemia and death following treatment of intraocular retinoblastoma with primary chemotherapy. Presented at the X International Congress of Ocular Oncology. 2001;. Amsterdam, June.
50. White L. Chemotherapy in retinoblastoma Current status and future directions . Am J Paediatric Haemotol/Oncol. 13:1991;189-201.